Randomized Trial of Orathecin and Gemcitabine Versus Placebo and Gemcitabine in Patients With Non-Resectable Pancreatic Cancer Who Have Not Already Received Chemotherapy.
Phase of Trial: Phase II/III
Latest Information Update: 22 Jan 2013
At a glance
- Drugs Gemcitabine; Rubitecan
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 22 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Oct 2009 Company added in the association field and additional lead trial center identified as reported by ClinicalTrials.gov.